Conmed (CNMD) Other financing activities (2010 - 2026)

Conmed's Other financing activities history runs 17 years deep, the most recent figure standing at $828000.0 for Q1 2026.

• Quarterly Other financing activities rose 278.45% year-over-year to $828000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 36.49% YoY) and the FY2025 annual result came in at $170000.0, down 94.0% from the prior year.
• Other financing activities was $828000.0 for Q1 2026 at Conmed, up from $4000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $65.9 million in Q2 2022 and bottomed at -$464000.0 in Q1 2025.
• A 5-year average of $6.1 million and a median of $828000.0 in 2026 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2022 — Other financing activities jumped 2351.9% — and 2025, when it tumbled 792.54%.
• Conmed's Other financing activities stood at $65.9 million in 2022, then tumbled by 98.1% to $1.2 million in 2023, then plunged by 83.6% to $205000.0 in 2024, then tumbled by 98.05% to $4000.0 in 2025, then surged by 20600.0% to $828000.0 in 2026.
• Business Quant data shows CNMD's Other financing activities at $828000.0 in Q1 2026, $4000.0 in Q4 2025, and $147000.0 in Q3 2025.